348 related articles for article (PubMed ID: 36275679)
21. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
Shi S; Wang Q; Du X
J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
[TBL] [Abstract][Full Text] [Related]
22. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
23. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
24. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
Yang L; Liu J; Liu S
BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
[TBL] [Abstract][Full Text] [Related]
26. LINC00960 affects osteosarcoma treatment and prognosis by regulating the tumor immune microenvironment.
Zhang Y; Lu G; Guan Y; Xu T; Duan Z; Li G
Heliyon; 2024 Feb; 10(3):e24990. PubMed ID: 38352756
[TBL] [Abstract][Full Text] [Related]
27. Identification and prognostic evaluation of differentially expressed long noncoding RNAs associated with immune infiltration in osteosarcoma.
Wang B; Wang X; Du X; Gao S; Liang B; Yao W
Heliyon; 2024 Mar; 10(5):e27023. PubMed ID: 38463807
[TBL] [Abstract][Full Text] [Related]
28. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
[TBL] [Abstract][Full Text] [Related]
29. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
30. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
[TBL] [Abstract][Full Text] [Related]
31. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
33. ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Comb Chem High Throughput Screen; 2023; 26(1):135-148. PubMed ID: 35388751
[TBL] [Abstract][Full Text] [Related]
34. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
Zhou P; Zhang J; Feng J; Wang G
Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
[TBL] [Abstract][Full Text] [Related]
35. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
36. Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma.
Qian H; Lei T; Hu Y; Lei P
Front Cell Dev Biol; 2021; 9():673827. PubMed ID: 33937273
[TBL] [Abstract][Full Text] [Related]
37. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
38. Identification and Development of an Age-Related Classification and Signature to Predict Prognosis and Immune Landscape in Osteosarcoma.
Hong J; Wang X; Yu L; Li J; Hu H; Mao W
J Oncol; 2022; 2022():5040458. PubMed ID: 36276293
[TBL] [Abstract][Full Text] [Related]
39. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
40. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
Wang Q; Zhang W; Guo Y; Li Y; Fu K
Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
